Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GNLX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Sentiment: bearish
Last trade: sell 42 days ago
Red flags: 5
71 filers reported a long position in GNLX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | $6.8M | 2.3M | +6.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $5M | 1.7M | -1% |
| Bleichroeder LP | $4.2M | 1.4M | Unchanged |
| BlackRock, Inc. | $1.3M | 439.6K | +8.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.3M | 439.2K | -3.2% |
| BANK OF AMERICA CORP /DE/ | $989.7K | 328.8K | +1.5% |
| VANGUARD FIDUCIARY TRUST CO | $711.4K | 236.3K | -6.1% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $696.5K | 231.4K | -17.6% |
| Global Retirement Partners, LLC | $685.8K | 227.9K | — |
| LPL Financial LLC | $475.2K | 157.9K | +13.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.